Tasimelteon

May 21, 2020

Insomnia Data 2020: US Leads in Global Insomnia Clinical Trials, Germany Leads Major European Markets and Japan Has Top Spot in Asia

May 13, 2020

Vanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ® for the Treatment of Patients with Smith-Magenis Syndrome

Jul 22, 2019

Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder

Dec 20, 2018

FDA Accepts HETLIOZ® (tasimelteon) Supplemental New Drug Application for Review in the Treatment of Jet Lag Disorder

Dec 10, 2018

Vanda Announces Positive Pivotal Study Results for HETLIOZ® (tasimelteon) in Patients with Smith-Magenis Syndrome

Sep 12, 2018

HETLIOZ® (Tasimelteon) Driving Study Demonstrates No Impairment in Next Morning Performance

May 23, 2018

HETLIOZ® (tasimelteon) Effective in Treating Jet Lag during Transatlantic Travel

Mar 05, 2018

HETLIOZ® (tasimelteon) Demonstrates Efficacy to Treat Jet Lag Disorder in an 8 Hour Phase Advance Clinical Study

Sep 29, 2017

Vanda to Present Scientific Posters at World Sleep 2017